{
  "meta": {
    "timestamp": "2025-01-06T08:42:25.618179",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "OraSure Technologies Inc",
      "symbol": "OSUR",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Revenue volatility and post-pandemic uncertainty due to declining COVID-19 testing demand",
            "Regulatory and compliance risks, including potential delays in product approvals and cybersecurity vulnerabilities",
            "Supply chain vulnerabilities due to reliance on third-party suppliers",
            "Intense competition in the diagnostics market, pressuring margins and market share"
          ],
          "controversies": [
            "Cybersecurity incident disclosed in April 2024, raising concerns about operational vulnerabilities",
            "Challenges in maintaining supply chain and labor force efficiency post-COVID-19"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Impact of COVID-19 on supply chain and labor force, affecting operational efficiency"
          ],
          "governance_issues": [
            "Regulatory scrutiny and compliance risks in a highly regulated industry"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "After 55% Revenue Drop, OraSure Bets on Proteomics and International ...",
              "snippet": "After 55% Revenue Drop, OraSure Bets on Proteomics and International Growth January 05, 2025 OSUR Q3 2024 Summary. OraSure Technologies reported a challenging third quarter, with revenues declining 55% year-over-year to $39.9 million, largely due to the completion of a major COVID-19 contract and declining revenues in other areas.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155692+00:00",
              "published_date": null,
              "source_hash": "575b5d716c444beb74dc230fae798b72"
            },
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "The manufacturing shift is part of a rebalance, post-COVID-19. In November of 2024, OraSure reported COVID-19 revenues of $2.2 million in its third quarter, a decrease of 96% from the year before ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155788+00:00",
              "published_date": null,
              "source_hash": "3bbf54f8cea725d1b21b6de4ba0b01e9"
            },
            {
              "url": "",
              "title": "OraSure Technologies NasdaqGS:OSUR Stock Report - Simply Wall St",
              "snippet": "OraSure Technologies: Nursing A COVID-19 Hangover Sep 10. Consensus EPS estimates upgraded to US$0.098 loss ... OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2022. Aug 10 ... OSUR has not had significant price volatility in the past 3 months compared to the US market.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155809+00:00",
              "published_date": null,
              "source_hash": "0b42b75683b4153865edb7dac56cfadc"
            },
            {
              "url": "",
              "title": "OraSure Reports Q3 '24 Revenue of $39.9 Million - Nasdaq",
              "snippet": "--OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended September 30 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155823+00:00",
              "published_date": null,
              "source_hash": "0784c238b249e4d27497759335e8a93a"
            },
            {
              "url": "",
              "title": "OraSure Technologies reports higher fourth-quarter revenue, job ... - WFMZ",
              "snippet": "OraSure Technologies Inc. announced fourth-quarter revenue Tuesday that almost doubled over the ... Because of the volatility of the COVID-19 market, the company provided a forecast only for the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155833+00:00",
              "published_date": null,
              "source_hash": "de3b3f5bbc7933dc0db0322cdb7f2071"
            },
            {
              "url": "",
              "title": "OraSure Reports Q3 '24 Revenue of $39.9 Million - Morningstar",
              "snippet": "BETHLEHEM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155844+00:00",
              "published_date": null,
              "source_hash": "5662671beb97e2e1022653f94d7bdf5d"
            },
            {
              "url": "",
              "title": "OraSure Technologies Inc, OSUR:NSQ profile - FT.com - Financial Times",
              "snippet": "OraSure Technologies Inc (OSUR:NSQ) company profile with history, revenue, mergers & acquisitions, ... Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. ... Revenue in USD (TTM) 224 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155854+00:00",
              "published_date": null,
              "source_hash": "a5c809c2699fae50e6a0c0badf1618a9"
            },
            {
              "url": "",
              "title": "OraSure Technologies (OSUR) Earnings Date and Reports 2025 - MarketBeat",
              "snippet": "When is OraSure Technologies' next earnings announcement? View the latest OSUR earnings date, analysts forecasts, earnings history, and conference call transcripts. ... Quarterly revenue fell 55.2% year-over-year to $39.92 million, ... AI and Strong Guidance Drive Post-Earnings Surge; History Hints at a Rebound for Toll Brothers After Earnings;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155864+00:00",
              "published_date": null,
              "source_hash": "0f8c47288877f3c669177c21d31cbea6"
            },
            {
              "url": "",
              "title": "OraSure Technologies reports second-quarter revenue of $85.4 ... - WFMZ",
              "snippet": "Revenue from InteliSwab, the company's Covid-19 test, was $47.5 million in the quarter, while other revenue -- which OraSure defines as \"core revenue\" -- was $37.9 million, up 3% year-on-year.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155874+00:00",
              "published_date": null,
              "source_hash": "a144ab45683b1de2010a810d6d8e5cff"
            },
            {
              "url": "",
              "title": "OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year ...",
              "snippet": "InteliSwab\u00ae revenue of $79.6 million in Q3, up 85% sequentially;Company continues to expand test production capacity Company wins new contracts for COVID-19 testing along with retail wins including availability on Amazon.com Q3 GAAP EPS of $0.07 and non-GAAP EPS of $0.13 Company generates positive cash flow from operations in quarter ahead of prior guidance Management to Host Analyst/Investor ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:56.155884+00:00",
              "published_date": null,
              "source_hash": "8884cd6e99a191251af459d6c4c1206c"
            },
            {
              "url": "",
              "title": "OraSure Technologies (NASDAQ:OSUR) Stock Rating Upgraded by StockNews.com",
              "snippet": "OraSure Technologies (NASDAQ:OSUR - Get Free Report) was upgraded by StockNews.com from a \"hold\" rating to a \"buy\" rating in a note issued to investors on Wednesday. OraSure Technologies Stock Down 1.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:58.593909+00:00",
              "published_date": "2025-01-03T05:36:00+00:00",
              "source_hash": "d371f2e0fb9725ecace03c692f17a7f0"
            },
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "President and CEO Carrie Eglinton Manner spoke to 69 News about what's on the horizon for the Bethlehem-based maker of medical diagnostic testing and collection devices.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:02.643923+00:00",
              "published_date": "2025-01-02T15:02:00+00:00",
              "source_hash": "f750b86210a4f65bceec4fce2b72055f"
            },
            {
              "url": "",
              "title": "OraSure Reports Q3 '24 Revenue of $39.9 Million",
              "snippet": "Nov. 06, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in ... progress on our strategic transformation. Core revenue improved sequentially in the third quarter ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:58.594046+00:00",
              "published_date": "2024-11-06T13:05:00+00:00",
              "source_hash": "49dc866f21d79923eec2fae46a0e23b7"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies, Inc. has announced the acquisition of ... the impact of the novel coronavirus (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:58.594071+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "15ed28919edfda480f741df7b7cbde13"
            },
            {
              "url": "",
              "title": "OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (\"OTI\") (NASDAQ ... Subject to regulatory approvals, revenue from Sherlock's CT/NG test is expected to contribute to OTI ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc revenue volatility post-COVID-19",
              "retrieved_at": "2025-01-06T15:41:58.594093+00:00",
              "published_date": "2024-12-19T21:10:00+00:00",
              "source_hash": "c71009f1fa891006328ac818cf268d06"
            },
            {
              "url": "",
              "title": "CA Declaration of Compliance - OraSure Technologies",
              "snippet": "CA Declaration of Compliance Corporate Compliance. As part of OraSure's ongoing efforts in the area of compliance, we have developed and implemented a comprehensive Corporate Compliance Program (the \"Compliance Program\") designed to comply with all applicable federal, state, and industry guidelines, relating to the marketing and promotion of our products to healthcare professionals, including ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145273+00:00",
              "published_date": null,
              "source_hash": "8010374a99deec2f37afd6f5577d12e6"
            },
            {
              "url": "",
              "title": "Orasure Technologies, Inc. Policy Statement on Dealing With Company ...",
              "snippet": "In the course of conducting the business of OraSure Technologies, Inc. (the \"Company\") ... The officer responsible for compliance with this Policy Statement is the Company's General Counsel (the \"Compliance Officer\"). ... or other regulatory submissions, approvals, investigations, reviews, audits or other actions or ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145299+00:00",
              "published_date": null,
              "source_hash": "41db18f66c8cc01a8df29de265e24bdb"
            },
            {
              "url": "",
              "title": "2024-04-12 ORASURE TECHNOLOGIES INC Cybersecurity Incident",
              "snippet": "ORASURE TECHNOLOGIES INC initially disclosed a cybersecurity incident in an SEC 8-K filing on 2024-04-12 16:45:30 EDT. Company Summary Incident Details Filings 8-K filed on 2024-04-12 Company Information Company Summary OraSure Technologies is a Bethlehem, Pennsylvania-based company in the medical device industry. Their products include diagnostic testing kits. The company had recently ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145309+00:00",
              "published_date": null,
              "source_hash": "042cb1ed935f4ae748a89eb15f3099b7"
            },
            {
              "url": "",
              "title": "Files taken from Orasure systems in cybersecurity incident",
              "snippet": "While Orasure believes it has contained the incident, it was still assessing \"what, if any, regulatory and legal notifications are required.\" The findings of an investigation into the incident and whether personal data was accessed will inform the next steps. Orasure described its cybersecurity approach in a March annual financial filing ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145316+00:00",
              "published_date": null,
              "source_hash": "decb6b69e80cff53d95a5649f507e0fd"
            },
            {
              "url": "",
              "title": "OraSure Technologies Data Breach Investigation",
              "snippet": "OraSure Technologies is a medical equipment manufacturing company based in Pennsylvania.Founded in 1987, OraSure Technologies, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. 2 Additionally, OraSure Technologies and its family of companies are leaders in the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145322+00:00",
              "published_date": null,
              "source_hash": "89158ecbf662e7191bf7d8c006498ff0"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "#1.0 - Filed 11/14/2024: COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17881567.), filed by ORASURE TECHNOLOGIES, INC..(JOHNSON, THOMAS) - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145352+00:00",
              "published_date": null,
              "source_hash": "8d2801e8d37bbad9c2e6e24d1d667a6f"
            },
            {
              "url": "",
              "title": "Orasure Technologies, Inc. Code of Business Conduct and Ethics",
              "snippet": "ORASURE TECHNOLOGIES, INC. CODE OF BUSINESS CONDUCT AND ETHICS (As amended through November 14, 2023) Introduction . The reputation and integrity of OraSure Technologies, Inc. (together with its subsidiaries, the \"Company\" or \"we\") are valuable assets that are vital to the Company's success. Each director,",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145358+00:00",
              "published_date": null,
              "source_hash": "79eb9f26e8741d0ed31d9b4e525bf065"
            },
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "BETHLEHEM, Pa.- OraSure Technologies will lean into innovation in the new year, as it continues to chart its post-pandemic future. President and CEO Carrie Eglinton Manner, who stepped into the ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:06.698892+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "caef4ae6b9de98d68a562b28b5e90e99"
            },
            {
              "url": "",
              "title": "Supplier Transparency - OraSure Technologies",
              "snippet": "This statement is made in accordance with, and relates to the fiscal year ended December 31, 2023 and includes the activities of OraSure Technologies, Inc. (\"OraSure\") and its wholly-owned subsidiaries, DNA Genotek Inc. (\"DNAG\"), Diversigen, Inc. (\"Diversigen\") and Novosanis N.V. (\"Novosanis\") (collectively the \"Company\").",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258650+00:00",
              "published_date": null,
              "source_hash": "56eaf26087278312f658baef7bdd687d"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. ESG Risk Rating - Sustainalytics",
              "snippet": "OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:00.145375+00:00",
              "published_date": null,
              "source_hash": "41b63cb3be5221353ff8297c0b471362"
            },
            {
              "url": "",
              "title": "OraSure Technologies: Return To Profitability Is Uncertain",
              "snippet": "OraSure Technologies makes tests for HIV ... investors who may not be licensed or certified by any institute or regulatory body.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:02.643989+00:00",
              "published_date": "2024-12-19T05:59:00+00:00",
              "source_hash": "20d31223fab68fd62f2d1446b2e2307d"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies, Inc. has announced the acquisition of ... infections like Chlamydia and Gonorrhea, with plans for regulatory approval by the end of 2025. This acquisition aims to leverage ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:02.644004+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "a005500c2013976950df0ac34f3c7eb8"
            },
            {
              "url": "",
              "title": "OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies emphasizes its commitment to the integration of Sherlock's business and the expected benefits of this acquisition, including seeking and obtaining regulatory approvals for ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:02.644017+00:00",
              "published_date": "2024-12-27T00:00:00+00:00",
              "source_hash": "6b768714589f1ee47a3ad9a7f699743d"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Receives $7.5 Million Award for Development of Rapid Antigen Test for Marburg Virus Disease",
              "snippet": "OraSure Technologies received a $7.5 million contract to develop a rapid antigen test for Marburg Virus Disease. OraSure Technologies, Inc. announced ... exposure to regulatory challenges, as ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T15:42:02.644029+00:00",
              "published_date": "2024-12-02T12:11:00+00:00",
              "source_hash": "5dc086a2b6a3a9eb4b6120602762d8fe"
            },
            {
              "url": "",
              "title": " Orasure Technologies Annual Report 2022 - stocklight.com",
              "snippet": "Orasure Technologies Annual Report 2022 Form 10-K (NASDAQ:OSUR) Published: March 1st, 2022 ... \u2022the impact of COVID-19 on our supply chain; \u2022our ability to successfully develop new products, validate the expanded use of existing collector products, receive necessary regulatory approvals ... \u2022customer consolidations and inventory practices;",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258756+00:00",
              "published_date": null,
              "source_hash": "dca54053601b497d5e012da0b591852b"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Secures Strategic Distribution - GlobeNewswire",
              "snippet": "About OraSure Technologies, Inc. ... pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of existing collector ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258777+00:00",
              "published_date": null,
              "source_hash": "673bbe1eb83eb3fb7c3b19e9500413c0"
            },
            {
              "url": "",
              "title": "OraSure Reports Q3 '24 Revenue of $39.9 Million - Markets Insider",
              "snippet": "OraSure Technologies, Inc. (\"OraSure\") transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. ... supply chain, labor force ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258789+00:00",
              "published_date": null,
              "source_hash": "566b68af5cc03452e291e86ee7881199"
            },
            {
              "url": "",
              "title": "OraSure Technologies Acquires Sherlock Biosciences - GlobeNewswire",
              "snippet": "About OraSure Technologies, Inc. ... pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of existing collector ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258800+00:00",
              "published_date": null,
              "source_hash": "2cc011fe018d134fde3e209c5405dc8a"
            },
            {
              "url": "",
              "title": "OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year ...",
              "snippet": "OraSure Technologies, Inc. ... (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of existing ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258810+00:00",
              "published_date": null,
              "source_hash": "adcd878242bcce78539fe787c94d876c"
            },
            {
              "url": "",
              "title": " OraSure Technologies - Seeking Alpha",
              "snippet": "Confidential \u00a9 2021 OraSure Technologies, Inc. 5 Improving Global Access to Accurate Healthcare Information Experts in sample collection, preservation and diagnostics",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258819+00:00",
              "published_date": null,
              "source_hash": "00b7debabbb861cafc82c4dfd652eeff"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with ...",
              "snippet": "About OraSure Technologies, Inc. ... pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of existing collector ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258829+00:00",
              "published_date": null,
              "source_hash": "f22d2bf8b5248be01633f7fe41ae9c54"
            },
            {
              "url": "",
              "title": "OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "About OraSure Technologies, Inc. OraSure Technologies, Inc. (\"OraSure\") transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. ... the impact of the novel coronavirus (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability to successfully ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258838+00:00",
              "published_date": null,
              "source_hash": "4aad9c1fa56e96eae0eb6bd8cee83a77"
            },
            {
              "url": "",
              "title": "OraSure Technologies Elects Jack Kenny to the Board of Directors",
              "snippet": "About OraSure Technologies OraSure Technologies, Inc. (\"OraSure\") transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. ... (\"COVID-19\") pandemic on OraSure's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:04.258849+00:00",
              "published_date": null,
              "source_hash": "deeeff9e3de9434ae0f754bb0b7d40a2"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Receives $7.5 Million Award for Development of Rapid Antigen Test for Marburg Virus Disease",
              "snippet": "OraSure Technologies received a $7.5 million contract to develop a rapid antigen test for Marburg Virus Disease. OraSure Technologies, Inc. announced ... OraSure's business, supply chain, labor ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:06.698784+00:00",
              "published_date": "2024-12-02T12:11:00+00:00",
              "source_hash": "87b29709328a701e40bc8e4f05f91eb5"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies, Inc. has announced the acquisition of ... (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:06.698924+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "83ec4f85ee1771614cd07c1980bcb5bd"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc.: OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "About OraSure Technologies, Inc. OraSure Technologies, Inc. (\"OraSure\") transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:06.698950+00:00",
              "published_date": "2024-12-19T22:06:00+00:00",
              "source_hash": "f72ddfb87d7bc2d802d272a7ed4e5d40"
            },
            {
              "url": "",
              "title": "OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "For additional information, read OraSure Technologies's 8K filing here. OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain labor practices",
              "retrieved_at": "2025-01-06T15:42:06.698974+00:00",
              "published_date": "2024-12-27T00:00:00+00:00",
              "source_hash": "37cb9eef9742399f1ba0ef71c2a47610"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "OraSure Technologies Inc revenue volatility post-COVID-19",
              "rationale": "Investigate the company's financial stability and sustainability after the pandemic-driven demand for COVID-19 testing products declines.",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "OraSure Technologies Inc regulatory compliance issues",
              "rationale": "Examine potential delays in product approvals or compliance challenges due to stringent regulatory requirements in the diagnostics industry.",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "OraSure Technologies Inc supply chain labor practices",
              "rationale": "Assess ethical concerns related to labor practices among third-party suppliers, given the company's reliance on external manufacturers.",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T08:42:25.618197",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}